RhumbLine Advisers’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.8M Buy
217,541
+2,733
+1% +$586K 0.03% 417
2026
Q1
$47.5M Buy
214,808
+1,064
+0.5% +$260K 0.04% 375
2025
Q4
$54.2M Buy
213,744
+1,052
+0.5% +$264K 0.04% 328
2025
Q3
$52.6M Sell
212,692
-2,245
-1% -$537K 0.04% 346
2025
Q2
$51.6M Buy
214,937
+3,506
+2% +$816K 0.04% 341
2025
Q1
$47.9M Buy
211,431
+11,921
+6% +$2.62M 0.04% 358
2024
Q4
$41M Sell
199,510
-4,261
-2% -$935K 0.04% 399
2024
Q3
$49.4M Sell
203,771
-2,076
-1% -$485K 0.04% 342
2024
Q2
$45.2M Sell
205,847
-3,082
-1% -$670K 0.04% 356
2024
Q1
$47M Buy
208,929
+5,725
+3% +$1.29M 0.05% 347
2023
Q4
$44.7M Sell
203,204
-1,074
-0.5% -$227K 0.05% 333
2023
Q3
$44.8M Sell
204,278
-2,897
-1% -$655K 0.05% 313
2023
Q2
$46.6M Sell
207,175
-4,879
-2% -$976K 0.05% 318
2023
Q1
$40.6M Buy
212,054
+8,631
+4% +$1.67M 0.05% 334
2022
Q4
$37.6M Sell
203,423
-3,534
-2% -$621K 0.05% 347
2022
Q3
$34.4M Buy
206,957
+10,794
+6% +$2.2M 0.05% 341
2022
Q2
$40.4M Buy
196,163
+9,183
+5% +$2.07M 0.06% 285
2022
Q1
$45.2M Buy
186,980
+7,086
+4% +$1.64M 0.06% 287
2021
Q4
$43.8M Sell
179,894
-432
-0.2% -$98.7K 0.05% 308
2021
Q3
$36.8M Sell
180,326
-9,503
-5% -$2.03M 0.05% 332
2021
Q2
$39.2M Buy
189,829
+19,603
+12% +$3.95M 0.05% 322
2021
Q1
$32.4M Sell
170,226
-8,753
-5% -$1.62M 0.04% 375
2020
Q4
$33.9M Sell
178,979
-17,307
-9% -$3.23M 0.05% 353
2020
Q3
$34.6M Buy
196,286
+9,311
+5% +$1.49M 0.05% 306
2020
Q2
$28.7M Sell
186,975
-16,640
-8% -$2.53M 0.05% 348
2020
Q1
$28.5M Buy
203,615
+35,792
+21% +$5.35M 0.06% 287
2019
Q4
$25.6M Sell
167,823
-72,340
-30% -$10.6M 0.04% 392
2019
Q3
$34.7M Buy
240,163
+143
+0.1% +$21.4K 0.06% 280
2019
Q2
$35.7M Buy
240,020
+16,181
+7% +$2.16M 0.07% 275
2019
Q1
$28.7M Sell
223,839
-7,852
-3% -$924K 0.06% 311
2018
Q4
$24.8M Buy
231,691
+73,222
+46% +$8.18M 0.05% 329
2018
Q3
$18.1M Sell
158,469
-3,369
-2% -$381K 0.04% 472
2018
Q2
$17M Buy
161,838
+1,629
+1% +$164K 0.03% 488
2018
Q1
$15M Sell
160,209
-5,854
-4% -$532K 0.03% 529
2017
Q4
$14.5M Buy
166,063
+14,410
+10% +$1.29M 0.03% 553
2017
Q3
$13.4M Buy
151,653
+2,790
+2% +$236K 0.03% 554
2017
Q2
$12.1M Buy
148,863
+74,620
+101% +$5.67M 0.03% 566
2017
Q1
$5.16M Buy
74,243
+292
+0.4% +$20.2K 0.01% 985
2016
Q4
$4.98M Sell
73,951
-305
-0.4% -$20.7K 0.01% 937
2016
Q3
$5.43M Sell
74,256
-2,980
-4% -$211K 0.02% 843
2016
Q2
$5.31M Sell
77,236
-83,388
-52% -$5.84M 0.02% 799
2016
Q1
$11.4M Buy
160,624
+8,380
+6% +$567K 0.04% 482
2015
Q4
$11.5M Buy
152,244
+36,875
+32% +$2.66M 0.04% 464
2015
Q3
$7.5M Buy
115,369
+5,015
+5% +$331K 0.03% 621
2015
Q2
$7.11M Sell
110,354
-2,310
-2% -$156K 0.02% 669
2015
Q1
$7.92M Buy
112,664
+15,368
+16% +$1.01M 0.02% 616
2014
Q4
$6.31M Sell
97,296
-2,315
-2% -$143K 0.02% 674
2014
Q3
$5.38M Buy
99,611
+1,655
+2% +$90K 0.02% 735
2014
Q2
$5.24M Sell
97,956
-10,197
-9% -$525K 0.02% 783
2014
Q1
$5.16M Sell
108,153
-3,480
-3% -$163K 0.02% 803
2013
Q4
$5.36M Sell
111,633
-1,693
-1% -$77.4K 0.02% 784
2013
Q3
$4.87M Sell
113,326
-68
-0.1% -$2.95K 0.02% 811
2013
Q2
$4.86M Buy
+113,394
New +$4.88M 0.02% 781

Other funds holding STE

RhumbLine Advisers's STE Position: Q2 2026 in Review

RhumbLine Advisers increased its Steris (STE) stake by 1.3% in Q2 2026, buying an estimated $586K and bringing the position to 217,541 shares worth $45.8M. The position accounts for 0.03% of the portfolio, ranked #417.

RhumbLine Advisers first reported a position in STE in Q2 2013 and has held it in 53 quarters since. The position peaked at $54.2M in Q4 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • RhumbLine Advisers held 217,541 shares of Steris worth $45.8M as of Q2 2026.
  • RhumbLine Advisers bought 2,733 Steris shares in Q2 2026, an estimated $586K.
  • Steris made up 0.03% of RhumbLine Advisers's portfolio in Q2 2026, its #417 holding.
  • RhumbLine Advisers first reported a position in Steris in Q2 2013 and has held it in 53 quarters since.
  • RhumbLine Advisers's Steris position peaked at $54.2M in Q4 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.